SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Spacemesh developer Unruly Technologies files for insolvency

Innovation Authority selects two new Deep Tech incubators to focus on energy, infrastructure, and medical tech

Microsoft overtakes Apple as world’s most valuable company amid tariff turbulence

Inside NSO’s WhatsApp hack: $40 million in profit and 1,223 global targets

More stories 24more

24more

Buzz

Most popular

Daily

Weekly

1

Palo Alto Networks founder Nir Zuk: “We can’t keep relying on cyber as the engine of Israeli high-tech”

2

OrCam closing glasses department, cutting dozens of jobs in third round of layoffs this year

3

Cato Networks in talks to raise $300M at $4.5B valuation as IPO window narrows

4

Coho AI shuts down, Yotpo to integrate employees amid quiet exit

5

Israel’s economic footprint in Florida grows as Israeli-founded companies boost jobs and innovation

Buzzmore

Polypid

6 stories about Polypid

מוסף ניתוח מנתחים רופא רופאים חדר ניתוח

Biotech Company Polypid Raises $15 Million

07.11.18|Lilach Baumer

Israel-based Polypid develops encapsulating drug delivery technology that enables extended and localized release in the body

CTech’s Sunday Roundup of Israeli Tech News

U.S. court charges Israeli CEO with binary options fraud. Stock market downturn leads biotech company Polypid to backtrack on IPO

חיים הורביץ איש עסקים דירקטור ב חברת טבע

Stock Market Downturn Leads Biotech Company Polypid to Backtrack on IPO

25.03.18|Dror Reich

The Israel-based company has postponed its planned IPO after Nasdaq, Dow Jones trended down heavily last week

אלביט מערכות נתנאל גרופ פארק תמר רחובות

CTech’s Thursday Israeli Tech News Roundup

Israel-based defense and homeland security manufacturer and contractor Elbit wins a $65 million contract with an unnamed Asian-Pacific country. In protest of new bonus plan, Teva sued by Israeli employees

נאסדק נאסד"ק ניו יורק בורסה בועה

Biotech Company Polypid Aims to Raise $75 Million with Nasdaq IPO

15.03.18|Dror Reich

The Israel-based company develops a pharmaceutical mechanism that slows down drug delivery

Controlled Drug Release Company Polypid Attempts Second Nasdaq IPO

11.02.18|Dror Reich

The Israel-based company is looking to raise up to $86.25 million to fund clinical development and trials and manufacturing activities